Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Journal of the American Academy of Dermatology, 91 (3), AB309
Effective treatment requires careful patient selection based on BMI and comorbidities, along with managing patient expectations
1 Because compounders are not required to monitor or report adverse events, there is no safety data available on the combination
The typical starting dose is 0.25 mg once weekly for four weeks, followed by an increase to 0.5 mg once weekly
US$ 25.13
US$ 27.40
US$ 24.08
US$ 28.02
US$ 28.87
&srotate=0)
